About JB2C

Dr Chris Arts is Associate Professor Translational Biomaterials Research at Department of Orthopaedic Surgery Maastricht University Medical Centre (MUMC) and Eindhoven University of Technology (Faculty Biomedical Engineering). His Ph.D. thesis at Radboud University Medical Centre Nijmegen (2006) focused on the usability of calcium phosphate ceramic materials during hip arthroplasty revision surgery with the bone impaction grafting technique. Chris joined the Laboratory for Experimental Orthopedics in 2008.

Dr Chris Arts is working in the field of translational biomaterials research with research from cell lines to clinical studies. His expertise is on clinical application of biomaterials and mechanical and biological assessment of efficacy and safety. Focus is on development on biomaterials for use in infection prevention and treatment and spinal deformity treatment. Furthermore, he is working on development of high-resolution imaging techniques to visualize incorporation, degradation of biomaterials in vivo in clinical patients. 3-D printing of medical devices or implants for bone healing is another one of his research pursuits. Chris has co-authored about 85 publications in peer-reviewed international journals and several book chapters

Chris has a University Teaching Qualification (UTQ/BKO) and fulfills teaching roles in the Master Biomedical Sciences (FHML, UM), AKO (FHML, UM) and Master Medical Engineering (BMT, TU Eindhoven) programs. He currently supervises 11 PhD students of which 6 as primary promotor.

In conjunction with several societies, he is active in setting up new initiatives in biomaterials education for both academia and industry. In 2018, he initiated the Translational Orthopaedic Biomaterial Interest Group (TOBIG) to raise more awareness about education relating to bone graft substitute materials (www.tobig.eu).

Research Projects

  • TKI-Health Holland Ambition project
  • Chemelot InSciTe Posture
  • Interreg Prosperos


Services medical devices and biologics

1. Advisory board participation
  • Material portfolio assessment according to ISO 13485 & ISO 14155
  • Biomaterials and medical devices
  • Research project prioritization
  • KOL management
  • Biomaterials : Calcium Phosphate materials, bone grafts, bioactive glass, bone graft substitutes, PRP
  • Medical devices orthopaedic surgery: CoCr, stainless steel, Ti, UHMWPE
2. Animal & clinical research support
  • Animal and clinical study design according to GCP and ISO 14155
  • Safety and efficacy evaluation of biomaterials, medical devices and biologics
  • Analysis and reporting study outcome
3. Education & training
  • Bio(material) properties, clinical indications, medical imaging presentation for academic and industry
  • Preparation of product specific education and training materials
  • Speaker bureau participation and invited lectures
4. In vitro & in vivo study analysis
  • Biomaterial and medical device mechanical properties analysis
  • Biomaterial and medical device animal study analysis
  • Imaging analysis cell-material interaction
  • Clinical study outcome analysis
5. Technology & innovation assessment
  • Comprehensive technology & innovation evaluation
  • Material and medical education for academia and industry
  • Prioritization and recommendation of additional product medical application fields
6. Antimicrobial Resistance (AMR)
  • in vitro experiments
  • in vivo experiments
  • Clinical trial experiments
  • Keynote lecturing
  • Material portfolio assessment

Let's get in touch